Tag: Stock pick

Investors often target blue-chip ASX 200 shares for lower volatility and consistent earnings. 

It’s often assumed that because these companies are well-established, there is limited upside. 

However, here are some blue-chip stocks that have recently received price targets from brokers indicating upside of 20% or more. 

Qantas Airways Ltd (ASX: QAN)

With oil prices skyrocketing and geopolitical tension impacting global travel, Qantas shares have faced some volatility recently. 

The company noted that it is facing uncertainty due to Middle East tensions and rising jet fuel refining margins. 

However, it has hedged crude oil exposure and remains confident in fuel supply through April and May. 

Strong international demand – especially to Europe – has led the airline to redeploy aircraft and cut domestic capacity, with higher airfares expected to lift unit revenue by about 5% in the second half of FY26.

These headwinds have pushed its stock price down by 12% year to date. 

In good news for prospective buyers, the Qantas share price could now be a significant value. 

Macquarie recently placed a $11 price target on the airline’s shares, which would be a 20% rise from the share price at the time of writing. 

As a bonus, experts are tipping a healthy dividend yield for the ASX 200 company throughout the next few years. 

Telix Pharmaceuticals Ltd (ASX: TLX)

Like many ASX 200 healthcare shares, the Telix stock price has fallen heavily in the last 12 months. 

However, the commercial-stage biopharmaceutical company has rebounded significantly over the past month. 

Brokers believe this could be the start of a longer rally. 

Recently, Bell Potter placed a buy rating and $19 price target on Telix shares after the company announced the refinancing of its convertible note facility. 

The share price at the time of writing is hovering around $14.59, which indicates an upside potential of 30%. 

Life360 Inc (ASX: 360)

Despite now climbing 26% over the last 6 days at the time of writing, the Life360 share price remains significantly below its yearly highs. 

The company’s core product is a private family and friends social networking app that allows users to communicate and share their locations.

At the time of writing, this ASX 200 stock is exchanging hands for $22.72 per share. 

However, this is significantly below the $36.02 average price targets of 10 analysts via TradingView. 

Should this ASX 200 stock reach that level in the next 12 months, it would be a 58% rise from current levels. 

The post 3 ASX 200 shares tipped to rise 20% or more appeared first on The Motley Fool Australia.

More reading

• Experts name 3 ASX 200 tech shares to buy now
• 2 ASX shares highly recommended to buy: Experts
• These are the 10 most shorted ASX shares
• ASX 200 tech shares rocket 13% as long-awaited sector rebound accelerates
• Top brokers name 3 ASX shares to buy next week

Motley Fool contributor Aaron Bell has positions in Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Life360 and Macquarie Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are looking to take advantage of recent weakness in the tech sector, then it could pay to listen to what analysts are saying this week, courtesy of The Bull.

That’s because three ASX 200 tech shares have just been named as buys. Let’s see what they are recommending:

Aristocrat Leisure Ltd (ASX: ALL)

The team at Catapult Wealth thinks that Aristocrat Leisure could be an ASX 200 tech share to buy this week.

It believes that AI disruption concerns are overblown and have created a buying opportunity for investors. It explains:

Aristocrat makes and distributes slot machines and is a major player in online casinos. Aristocrat’s share price has fallen considerably this calendar year, driven partly by the fear of artificial intelligence (AI) competition and currency related issues. While AI does increase the risk of competition via new entrants, particularly in the online space, the highly regulated nature of the industry provides some protection for Aristocrat.

We believe any risk to Aristocrat’s position is overblown, and this weakness presents an opportunity to buy a company with a strong history of earnings growth at the lower end of its historic multiples range.

Life360 Inc (ASX: 360)

Analysts at Bell Potter have named location technology company Life360 as a tech share to buy now.

The broker believes that its shares offer an attractive risk-reward profile at current levels. Bell Potter explains:

This information technology company provides a mobile networking safety app for families. The company offers a compelling growth story driven by its unique position at the intersection of safety, connectivity and subscription-based monetisation. With accelerating premium subscriber growth alongside improving unit economics, the company continues to benefit from strong engagement and pricing power.

The integration of hardware and software ecosystems provide options for further monetisation, while operating leverage is beginning to emerge. Given strong top line momentum, expanding margins and the recent sell-off in line with the broader technology sector, Life360 presents an attractive risk-reward profile, particularly at current levels.

Xero Ltd (ASX: XRO)

Bell Potter has also named cloud accounting platform provider Xero as an ASX 200 tech share to buy.

The broker thinks that AI disruption fears are unwarranted and that recent share price weakness has created a buying opportunity for investors. It commented:

This accounting software provider remains a high quality business, underpinned by strong subscriber growth and increasing average revenue per user through product expansion. Xero continues to improve operating leverage as the business scales up globally, with margins expected to expand in response to cost discipline. Importantly, Xero is transitioning from a growth-at-all-costs model to one focused on profitability and cash generation, which should support a re-rating in valuation.

With a large addressable small-to-medium sized market and increasing penetration of digital accounting, Xero is well positioned to deliver sustained double-digit earnings growth. Near term catalysts include further margin upgrades and continued execution across key regions. We believe concerns related to the impact of artificial intelligence are overblown, and the share price sell-off presents a compelling buying opportunity.

The post Experts name 3 ASX 200 tech shares to buy now appeared first on The Motley Fool Australia.

More reading

• 2 ASX ETFs that could be a perfect for a tech rally
• How to build a $500,000 ASX share portfolio step by step
• ASX 200 tech shares rocket 13% as long-awaited sector rebound accelerates
• Which ASX 200 tech stock has Bell Potter just downgraded?
• The tech rally is back: here are 5 ASX shares leading the charge

Motley Fool contributor James Mickleboro has positions in Life360 and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Xero. The Motley Fool Australia has positions in and has recommended Life360 and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Building a portfolio in 2026 does not need to start with dozens of positions.

In many cases, a small number of well-chosen exchange traded funds (ETFs) can do most of the heavy lifting. The trick is finding funds that each play a clear role, so they work together rather than overlap.

Here are three ASX ETFs that could form the backbone of a portfolio this year.

VanEck MSCI International Quality ETF (ASX: QUAL)

The first ASX ETF to consider is the VanEck MSCI International Quality ETF.

Instead of chasing the fastest-growing companies, this fund leans into consistency.

It focuses on businesses with strong returns on equity, stable earnings, and low debt. These are often the companies that quietly keep delivering, regardless of the economic backdrop.

Its holdings include Microsoft (NASDAQ: MSFT), Apple (NASDAQ: AAPL), and Visa (NYSE: V).

What makes the fund interesting in a portfolio is its role as a stabiliser. It does not rely on one theme or one cycle. It is built around the idea that high-quality businesses tend to keep compounding over time. It was recently recommended by analysts at VanEck.

iShares S&P 500 ETF (ASX: IVV)

Another ASX ETF that could form a core position is the iShares S&P 500 ETF.

It is often seen as a simple way to invest in the US market, but it can also be thought of as a proxy for global innovation.

Many of the world’s most influential companies are listed in the United States, and this ETF gives broad exposure to them in one trade.

Its holdings include NVIDIA (NASDAQ: NVDA), Amazon.com (NASDAQ: AMZN), and Alphabet (NASDAQ: GOOGL).

The strength of the iShares S&P 500 ETF is coverage. It does not try to pick winners. It owns the market, allowing the biggest and most successful companies to naturally take up more space over time.

BetaShares Australian Quality ETF (ASX: AQLT)

A third ASX ETF that could complete the picture is BetaShares Australian Quality ETF.

It applies a similar quality lens as the VanEck MSCI International Quality ETF, but to ASX shares.

It selects companies based on factors like profitability, earnings stability, and balance sheet strength. This results in a portfolio that looks quite different to the broader ASX 200.

Its holdings can include names such as BHP Group Ltd (ASX: BHP), Commonwealth Bank of Australia (ASX: CBA), and Wesfarmers Ltd (ASX: WES).

This means that rather than always being heavily weighted to just banks and miners, it tilts toward businesses with stronger underlying fundamentals. It was recently recommended by analysts at BetaShares.

The post 3 ASX ETFs to build a portfolio around in 2026 appeared first on The Motley Fool Australia.

More reading

• Best and worst case scenarios this week for global equities: Expert
• A 2026 market crash could be a once-in-a-decade chance to build a $1 million ASX portfolio
• How to build a $500,000 ASX share portfolio step by step
• Why this ASX ETF is one of the best buys for Australians
• Stop ‘saving’, start investing! How to target a $1 million ASX share portfolio

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Apple, Microsoft, Nvidia, Visa, Wesfarmers, and iShares S&P 500 ETF and is short shares of Apple. The Motley Fool Australia has recommended Alphabet, Amazon, Apple, BHP Group, Microsoft, Nvidia, Visa, Wesfarmers, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

NextDC Ltd (ASX: NXT) and Wesfarmers Ltd (ASX: WES) shares are popular with investors and feature in many portfolios across the country.

But which one should you buy this week if you don’t already own them?

To narrow things down, let’s see what analysts at Red Leaf Securities are saying about the two popular ASX 200 shares, courtesy of The Bull.

Here’s what they are recommending investors do with these shares right now:

NextDC shares

Red Leaf is recommending this leading data centre operator’s shares as a buy this week.

It highlights the company’s strong forward order book as a reason to buy. In addition, it notes that NextDC’s strategic partnerships and expanding data centre network leave it well-positioned to capitalise on structural tailwinds in digital transformation and infrastructure demand.

Commenting on the growing data centre operator, Red Leaf said:

Australia’s leading data centre operator provides connectivity and colocation services to cloud, enterprise and government clients across Australia and the Asia Pacific. Its network of certified facilities underpin critical digital infrastructure amid surging demand for cloud, artificial intelligence and high performance computing.

NextDC recently launched a $1 billion hybrid securities offer to fund expansion. A strong forward order book reflects institutional confidence in its long term growth. The company continues to build new facilities and sign strategic partnerships, positioning it to capture structural tailwinds in digital transformation and infrastructure demand.

Wesfarmers shares

Red Leaf isn’t as positive on Wesfarmers. It has named the Bunnings, Kmart, and Officeworks owner’s shares as a sell this week.

While it likes its strong network of retail brands, it is concerned about slowing consumer demand and cost pressures. In addition, it believes the company’s shares are largely fully valued now.

As a result, it has suggested that investors trim positions in Wesfarmers if they are seeking a more attractive risk-reward proposition.

Commenting on Wesfarmers and its shares, Red Leaf said:

Wesfarmers is a diversified industrial conglomerate. Major retail brands include Bunnings, Kmart, Target and Officeworks. Its businesses are household names, but recent trading suggests slowing consumer demand and cost pressures are weighing on sentiment.

With much of its value already priced in amid a mixed outlook on near term retail growth, Wesfarmers lacks fresh catalysts to drive meaningful upside. Trimming positions into strength may be prudent for investors seeking a better risk-reward proposition.

The post NextDC vs Wesfarmers shares: Which is a buy? appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Why NextDC, Viva Energy and NAB shares are catching investor interest on Monday
• How many Wesfarmers shares do I need to buy for $1,000 of annual passive income?
• NextDC rally comes to a halt. Here’s what just dropped
• NextDC reports 60% increase in contracted utilisation growth and higher capex guidance

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Global focus remains firmly on the ongoing conflict in Iran, as the Aussie market has lagged behind global equities. 

Fresh analysis from the team at Betashares has laid out the roadmap for a best and worst-case scenario this week. 

Global equities trending up

International stocks rose further last week, reflecting hopes around US-Iran peace talks.

Global equity markets have now staged a three-week rebound on peace-talk hopes. The S&P 500 Index (SP: .INX) is now trading above the levels prevailing just before the Iran war began.

According to Betashares, US stocks fell the least during the initial sell-off and have so far rebounded the hardest, with the NASDAQ-100 Index (NASDAQ: NDX) ending last week 6.9% above its 27 February weekly close.

Interestingly, while the NASDAQ-100 and S&P 500 continued to rise, the S&P/ASX 200 Index (ASX: XJO) dipped 0.15% last week.

Betashares Chief Economist David Bassanese said in a release today that, in theory, a two-week ceasefire deal was supposed to have included a reopening of the Strait of Hormuz. 

But within 24 hours of saying the Strait was open, Iran said it was closed again – due to the US’ own blockade of Iranian-linked ships. 

At the time of writing, there’s news of the US seizing an Iranian ship, for which Iran has vowed retaliation. Iran has also denied US reports suggesting talks were set to resume.  

Suffice to say confusion reigns supreme! If there’s one guiding light for markets, it’s the idea that the longer the war drags on and the higher oil prices go, the greater the political pressure on President Trump to cut a deal. In short, in TACO we trust – though patience is being tested.

The week ahead

Betashares commentary said this week we are facing a best and worst-case scenario.

• The worst-case scenario is Iranian attacks on US military ships, potentially even sinking one with casualties. That could spark an “all bets are off” resumption of US/Israel missile strikes, potentially including Iranian energy infrastructure, which in turn could spark Iranian attacks on energy and water infrastructure across the Middle East.
• The best-case scenario is no tit-for-tat ship attacks and an agreement to hold more talks. 

It will be worth keeping track of technology shares here in Australia after a strong rebound last week. 

At the time of writing, the S&P/ASX 200 Information Technology Index (ASX: XIJ) is up a further 1% today, after a massive rally last week.

How to target these sectors

For investors who expect the S&P 500 and/or NASDAQ-100 Index to keep rumbling ahead, there are several ASX ETFs that offer exposure: 

• iShares S&P 500 ETF (ASX: IVV)
• Vanguard S&P 500 US Shares Index ETF (ASX: V500)
• BetaShares NASDAQ 100 ETF (ASX: NDQ)

Meanwhile, if you expect Aussie tech to keep rising, the Betashares S&P ASX Australian Technology ETF (ASX: ATEC) is worth considering. 

The post Best and worst case scenarios this week for global equities: Expert appeared first on The Motley Fool Australia.

More reading

• Buy these exciting ASX ETFs for AI exposure
• This ASX shares and ETF mix could be the key to early retirement
• 2 ASX ETFs that could be a perfect for a tech rally
• A 2026 market crash could be a once-in-a-decade chance to build a $1 million ASX portfolio
• Vanguard ETF dividends to be paid today

Motley Fool contributor Aaron Bell has positions in BetaShares Nasdaq 100 ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Nasdaq 100 ETF and iShares S&P 500 ETF and is short shares of BetaShares Nasdaq 100 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

SKS Technologies Group Ltd (ASX: SKS) shares are back in focus after another strong session on Monday.

The stock is currently up 14.64% to $6.50, with buying picking up through the day. Earlier in the session, it climbed to a fresh record high of $6.57 before easing slightly as sellers stepped in.

That pullback followed a steady climb, with the stock pushing higher across most of the past 2 weeks.

Momentum continues to build

The latest move adds to what has already been a powerful run.

SKS shares are now up around 60% in 2026 alone. Over the past 12 months, the gain stretches to almost 300%, putting it among the top performers on the ASX over that period.

Short-term price action also points to consistent demand. The stock has now closed higher for 8 straight sessions, with daily gains reaching as much as 6.76% during that stretch.

Even without a fresh announcement today, buyers have continued to step in.

Last week’s update still filtering through

While there has been no news released today, the company did update the market late last week.

That announcement outlined a $210 million contract tied to data centre projects across Victoria and New South Wales. The deal expanded on earlier work, increasing the overall scope tied to an existing development.

Despite the size of the contract, the initial reaction was limited. The share price slipped 0.18% on the day, closing at $5.67.

The current move suggests the market is still adjusting to what that update could mean.

Data centre work driving the outlook

SKS operates across electrical and communications infrastructure, with growing exposure to large-scale data centre builds.

That part of the market has been gaining attention as demand for digital infrastructure continues to lift. Projects of this scale require complex electrical systems, which aligns with the company’s core capabilities.

The latest contract adds to a growing pipeline of work.

Following recent wins, SKS reported work on hand of roughly $350 million. That figure has been trending higher, supported by repeat contracts and expanding project scope.

Valuation back in focus

After a run of this size, the stock is attracting more attention from a broader group of investors.

SKS now carries a market capitalisation of around $747 million. At the same time, intraday moves like today’s pullback from record highs show that shorter-term trading activity is increasing.

Even so, the overall trend continues to hold up. Buying interest has continued to emerge on dips, with the stock holding above prior levels as momentum builds.

The post Up nearly 300% in a year, this ASX stock just hit another record high appeared first on The Motley Fool Australia.

More reading

• Best and worst case scenarios this week for global equities: Expert
• Up another 9%, how much higher can Zip shares go?
• Leading brokers name 3 ASX shares to buy today
• This ASX lithium stock just exploded 12%. Here’s what sparked it
• Up 2,000% in a year, why this ASX healthcare stock is in focus today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sks Technologies Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s been a wild ride for investors in Zip Co Ltd (ASX: ZIP) shares. The Zip share price has surged another 9.2% to $2.55 during Monday afternoon trade, capping off a remarkable run.

Over the past five trading days, the buy now, pay later provider is up 36%, and an eye-catching 69% over the past month alone. Zoom out, and the picture gets even more volatile. Zip shares are down 40% over the past six months, yet are still up 50.9% over the past year. Hectic barely covers it.

So, what’s driving the latest rally and do experts think there’s more to come?

Positive surprise and record cash

The catalyst was Zip’s third-quarter update, which appears to have reset market expectations. The company reported record cash EBITDA of $65.1 million for the quarter, marking a 41.5% increase on the prior corresponding period. That kind of growth tends to get attention, especially in a sector that has spent the past few years under pressure.

Even more importantly, management of Zip shares upgraded its full-year outlook. Zip now expects group cash EBITDA of at least $260 million, up from previous guidance of around $248.6 million. In a market that rewards positive surprises, that upgrade has clearly struck a chord with investors.

Scaling profitability

There’s also a broader narrative at play. Zip has spent the past few years tightening its operations, exiting underperforming markets, and focusing on profitability. The latest result suggests those efforts are paying off, with stronger margins and improved cost control starting to flow through.

On the strength side, Zip is showing it can scale profitably while maintaining solid customer growth. Its core markets are performing well, and improving credit quality and disciplined lending are helping to reduce risk. If the business can sustain this balance, Zip shares start to look far more compelling than they did during the sector’s downturn.

But the risks haven’t disappeared. Buy now, pay later remains a cyclical and competitive space, sensitive to consumer spending and economic conditions. Any slowdown in retail activity or deterioration in credit performance could quickly impact earnings. The recent share price surge also raises the question of how much good news is already priced in Zip shares.

That leaves investors weighing momentum against sustainability.

What next for Zip shares?

For now, the broker community is firmly in the bullish camp. Nine out of 11 analysts rate Zip shares as a strong buy, with the remaining two sitting at buy. The average 12-month price target stands at $3.80, implying around 49% upside from current levels. The most optimistic forecast goes as high as $5.40. That’s more than double the stock’s current price.

After such a rapid run, volatility is almost guaranteed. But if Zip continues to deliver on earnings and maintain its improved discipline, the rally may not be over just yet.

The post Up another 9%, how much higher can Zip shares go? appeared first on The Motley Fool Australia.

More reading

• Why Navigator Global, St Barbara, Vulcan Energy, and Zip shares are racing higher today
• These are the 10 most shorted ASX shares
• $10,000 invested in Zip shares one month ago is now worth…
• 3 ASX 200 stocks leaping higher in this week’s slumping market
• Why Eden Innovation, Elsight, Paladin Energy, and Zip shares are racing higher today

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Collins Foods Ltd (ASX: CKF)

According to a note out of Morgans, its analysts have retained their buy rating on this KFC-focused quick service restaurant operator’s shares with a slightly reduced price target of $12.50. While the broker has trimmed its net profit forecast to reflect deferred store openings, reset German acquired store economics, and lower European same store sales assumptions, it remains very positive. This is partly due to the strong performance of the KFC Australia business and its attractive valuation. Morgans sees potential upside of over 40% for investors from current levels. The Collins Foods share price is trading at $8.56 on Monday.

NextDC Ltd (ASX: NXT)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this data centre operator’s shares with a trimmed price target of $19.00. The broker believes the market is underappreciating the structural growth in areas like cloud computing, GPU demand, and artificial intelligence (AI). It believes this will drive significant growth for data centre capacity, which bodes well for NextDC. In fact, it estimates that the data centre market could grow as much as 27% per annum through to 2030, under its bull case scenario. In light of this, the broker believes NextDC shares could be worth buying at current levels. The NextDC share price is fetching $14.12 at the time of writing.

Pro Medicus Ltd (ASX: PME)

Another note out of Morgans reveals that its analysts have retained their buy rating on this health imaging technology company’s shares with a reduced price target of $210.00. Morgans has been fine-tuning its financial model for Pro Medicus, which includes deliberately setting a lower bar. It notes that its remodelled estimates prioritise achievability over optimism, stage implementation revenue conservatively, and mark foreign exchange to spot. Morgans believes this is the right framework for a stock where sentiment has been fragile. That said, the broker believes Pro Medicus’ story remains untarnished, highlighting that contract news flow since February has been exceptional. This includes ~$100 million in wins and renewals, all at higher pricing, with cardiology upsell gaining traction. The Pro Medicus share price is trading at $145.57 on Monday afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• How much could a $10,000 investment in these undervalued ASX 200 shares be worth in a year?
• Why NextDC, Viva Energy and NAB shares are catching investor interest on Monday
• Why did Morgans just lower its outlook on Collins Food and Pro Medicus shares?
• 3 under-the-radar ASX AI shares that could be the next WiseTech
• NextDC rally comes to a halt. Here’s what just dropped

Motley Fool contributor James Mickleboro has positions in Collins Foods, Nextdc, and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Collins Foods and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

European Lithium Ltd (ASX: EUR) shares are making noise again on Monday, with buying picking up quickly throughout the day.

The stock is up 12.25% to 27.5 cents, adding to a strong run that has been building over recent months.

That move leaves the shares up roughly 80% in 2026, as interest across lithium names starts to return following last year’s downturn.

There has been no shortage of volatility for European Lithium, but today’s jump stands out from the recent trend.

It comes after a new update was released to the market.

Here’s what investors are reacting to.

Full control of Tanbreez project locked in

In a statement to the ASX, European Lithium said Critical Metals Corp (NASDAQ: CRML) will move to full ownership of the Tanbreez rare earths project in Greenland.

The deal involves picking up the remaining 50.5% stake, bringing the project under a single owner.

European Lithium will keep a 7.5% free carried interest in Tanbreez.

This removes the split ownership and makes decision-making more straightforward.

Tanbreez is seen as one of the larger rare earths deposits globally, and full ownership helps move it closer to development.

Management also pointed to recent approval from the Greenland government, which clears a key step for the project.

Ownership shift brings clearer pathway

With one owner in place, attention now shifts to what happens next on the ground.

Joint venture structures can slow things down, especially when major funding decisions are involved.

Full ownership gives Critical Metals direct control over timelines, capital allocation, and development plans.

European Lithium still keeps exposure through its retained interest, but without being involved day to day.

That setup removes some of the unknowns around the project and is starting to draw interest from investors.

Lithium sentiment starts to turn

The update lands as conditions across battery materials begin to improve.

Lithium prices have lifted in 2026 after a long decline, with demand expectations picking up and supply looking tighter.

That change has started to show up across ASX-listed names, particularly those linked to large or strategic assets.

European Lithium is not a pure lithium producer, but its rare earths exposure still links into the broader electrification push.

As pricing steadies, investors are starting to revisit names that were sold down heavily last year.

Foolish Takeaway

This kind of move can pull attention back in quickly, especially after a strong run.

But the stock has already climbed a long way this year and still trades with large swings.

Keep in mind that moves like this can fade just as fast as they appear.

For me, this is one to watch rather than chase.

There are other ASX stocks where the setup looks more consistent and easier to follow.

The post This ASX lithium stock just exploded 12%. Here’s what sparked it appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Up 2,000% in a year, why this ASX healthcare stock is in focus today
• Why Monash IVF, NAB, Viva Energy, and Worley shares are falling today
• Why this $9 billion ASX stock is edging closer to record highs today
• Up 130% in a year, are Lynas Rare Earths shares still a good buy today?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

4DMedical Ltd (ASX: 4DX) is back on the radar after an active start to the week.

The stock is currently up 2.56% to $5.99 after earlier touching an intraday high of $6.38.

That pullback has come as the broader market softened, with the S&P/ASX 200 Index (ASX: XJO) down 0.1% to 8,935 points.

Even with today’s volatility, the overall trend remains strong. The shares are up roughly 50% in 2026 and 2,000% over the past year.

Here’s what was announced.

Several updates hit at the same time

According to the release, 4DMedical reported a series of developments across commercial, regulatory, and its upcoming inclusion in the ASX 200.

The company confirmed a contract with GlaxoSmithKline to support pulmonary drug development using its imaging technology.

GlaxoSmithKline is a global pharmaceutical and healthcare company headquartered in the UK. It develops vaccines, specialty medicines, and consumer health products, and is one of the largest drugmakers in the world.

The agreement runs for 1 year and will see 4DMedical provide lung imaging biomarkers across clinical trials.

4DMedical did not disclose the financial terms of the agreement.

At the same time, the company reported regulatory clearance in the UK for its CT:VQ technology.

CT:VQ is 4DMedical’s imaging technology that uses CT scans to map how air and blood move through the lungs. It produces detailed functional images that help clinicians detect and measure lung conditions without requiring invasive tests.

This follows CE Mark certification received in March and allows for immediate clinical use.

The UK is one of the largest markets for diagnostic imaging, with millions of chest scans performed each year.

The update also highlighted clearance for its coronary artery calcium analysis solution in Canada.

Reimbursement progress opens a revenue pathway

Another part of the release focused on progress in the United States.

A new reimbursement code has been established for AI-enabled coronary calcium analysis from CT scans.

The code allows hospitals to claim around US$15.50 per study in the outpatient setting.

This puts a clear revenue pathway in place without requiring additional imaging or changes to workflow. Providers can integrate the analysis into existing scans, which helps lower barriers to adoption.

Reimbursement has often been a key step in moving imaging technologies into routine clinical use.

ASX 200 entry puts the stock on more screens

4DMedical has also been added to the S&P/ASX 200 Index at market open today.

The move brings the stock into Australia’s main benchmark, which is tracked by institutional and passive funds.

Inclusion can lead to increased demand as index funds adjust their holdings.

It also increases visibility among larger investors and can improve liquidity over time.

The post Up 2,000% in a year, why this ASX healthcare stock is in focus today appeared first on The Motley Fool Australia.

More reading

• Worley flags $30–40m EBITA hit from Middle East conflict in FY26 outlook
• Viva Energy Group issues update on Geelong Refinery after fire
• Qube updates FY26 outlook: expects short-term headwinds but maintains earnings growth target
• National Australia Bank strengthens balance sheet ahead of 1H26 results
• NextDC reports 60% increase in contracted utilisation growth and higher capex guidance

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.